ACTA1 and cancer: Putative cPSCs were identified using immunocytochemistry: α-SMA+ (α-smooth muscle actin, PSC activation marker), CK− (pan-cytokeratin, epithelial/cancer marker), CD45− (leucocyte marker) and DAPI (nuclear staining) (Figure 3a and Figure A4).